Rethinking network analysis in ethnopharmacology: a multi-omics and AI roadmap to overcome conceptual and methodological biases
Frontiers in Pharmacology · 20.02.2026 · 17
DOI: 10.3389/fphar.2026.1748478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.02.2026. Verfasst von Xuewen Diao und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Henan University of Chinese Medicine Department of Andrology, Zhengzhou, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Network analysis (NA) is a widely used computational tool for exploring the complex systems of interactions in ethnopharmacology, aiming to predict potential targets and generate mechanistic hypotheses. However, the predictive validity and biological relevance of its outputs are constrained by a pervasive methodological bottleneck: the recurrent identification of a narrow set of molecules—such as quercetin—across disparate natural products and diseases. Through a systematic analysis of 1,038 network-based studies, we establish “homogeneity” as a coherent, multi-level pattern, from “Flavonoid Centrality” to a “Hub-Target Core” and restricted “Canonical Pathways,” transcending specific remedies or diseases. We conceptualize this as a self-reinforcing “convergent discovery pipeline,” in which initial database biases are amplified by context-insensitive analytical approaches. Empirical evidence shows that integrating contextual experimental or multi-omics data mitigates homogeneity. To break this cycle and align network analysis more closely with pharmacological best practices, we propose an integrated framework that shifts from database dependency to empirically driven data acquisition, leverages bias-aware artificial intelligence for curation and prioritization, and advances dynamic, context-specific network modeling. This framework provides a clear roadmap to disrupt methodological inertia and steer network-based research in ethnopharmacology toward a more robust, diverse, and pharmacologically and clinically relevant future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Henan University of Chinese Medicine Department of Andrology, Zhengzhou, China.
- The First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, China.
- Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao SAR, China.
- The First Affiliated Hospital of Henan University of Chinese Medicine Department, Zhengzhou, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
Zitieren
APA
Diao, X., Zhang, H., Wang, S., Wang, Z., & Zhang, Q. (2026). Rethinking network analysis in ethnopharmacology: a multi-omics and AI roadmap to overcome conceptual and methodological biases. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1748478
Vancouver
Diao X, Zhang H, Wang S, Wang Z, Zhang Q. Rethinking network analysis in ethnopharmacology: a multi-omics and AI roadmap to overcome conceptual and methodological biases. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1748478
BibTeX
@article{Diao2026,
author = {Diao, Xuewen and Zhang, Hao and Wang, Shiqi and Wang, Zulong and Zhang, Qi},
title = {Rethinking network analysis in ethnopharmacology: a multi-omics and AI roadmap to overcome conceptual and methodological biases},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1748478}
}
EUVIMED